|View printer-friendly version|
|August 04, 2006 1:55 p.m.|
|Teva Announces Final Approval of Venlafaxine HCL Tablets|
Jerusalem, Israel, August 4, 2006 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted final approval for the Company's Abbreviated New Drug Application ("ANDA") for Venlafaxine Hydrochloride Tablets, 25 mg, 37.5 mg, 50 mg, 75 mg and 100 mg. Shipment of this product will begin immediately.